SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Benitec Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-18 4:16 pm Sale | 2022-12-31 | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 177,660 9.990% | -194,617 (-52.28%) | Filing |
| 2023-02-13 12:25 pm Purchase | 2022-12-31 | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 372,276 9.990% | 327,041 (+722.98%) | Filing |
| 2021-05-07 4:46 pm Purchase | 2021-04-28 | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 45,235 9.800% | 45,235 (New Position) | Filing |